Earnings Feed
Sign Up
Home/Insiders/VENROCK ASSOCIATES II LP
VA
SEC Insider//CIK 0001239243

VENROCK ASSOCIATES II LP

CIK 00012392433 companiesNEW YORK, NY
SEC Profile

Transactions

50

Companies

3

Filings

3

CIK

0001239243

Recent Transactions

50 trades
  • Other
    XENOPORT INC

    Series D Preferred Stock

    2005-06-07+4,194→ 102,527 total
  • Other
    XENOPORT INC

    Series D Preferred Stock

    2005-06-07+4,194→ 102,527 total
  • Conversion
    XENOPORT INC

    Series D Preferred Stock

    2005-06-07−102,527→ 0 total
  • Conversion
    XENOPORT INC

    Common Stock

    2005-06-07+102,527→ 836,900 total
  • Conversion
    XENOPORT INC

    Series B Preferred Stock

    2005-06-07−346,920→ 0 total
  • Conversion
    XENOPORT INC

    Common Stock

    2005-06-07+236,000→ 269,453 total
  • Conversion
    XENOPORT INC

    Common Stock

    2005-06-07+118,000→ 734,373 total
  • Conversion
    XENOPORT INC

    Series A Preferred Stock

    2005-06-07−236,000→ 0 total
  • Conversion
    XENOPORT INC

    Common Stock

    2005-06-07+346,920→ 616,373 total
  • Conversion
    XENOPORT INC

    Series D Preferred Stock

    2005-06-07−102,327→ 0 total
  • Conversion
    XENOPORT INC

    Common Stock

    2005-06-07+102,327→ 836,700 total
  • Conversion
    XENOPORT INC

    Series C Preferred Stock

    2005-06-07−118,000→ 0 total
  • Conversion
    XENOPORT INC

    Series C Preferred Stock

    2005-06-07−118,000→ 0 total
  • Conversion
    XENOPORT INC

    Common Stock

    2005-06-07+102,327→ 836,700 total
  • Conversion
    XENOPORT INC

    Common Stock

    2005-06-07+236,000→ 269,453 total
  • Conversion
    XENOPORT INC

    Series A Preferred Stock

    2005-06-07−236,000→ 0 total
  • Conversion
    XENOPORT INC

    Common Stock

    2005-06-07+346,920→ 616,373 total
  • Conversion
    XENOPORT INC

    Series D Preferred Stock

    2005-06-07−102,327→ 0 total
  • Conversion
    XENOPORT INC

    Common Stock

    2005-06-07+118,000→ 734,373 total
  • Conversion
    XENOPORT INC

    Series B Preferred Stock

    2005-06-07−346,920→ 0 total
  • Conversion
    XENOPORT INC

    Common Stock

    2005-06-07+102,527→ 836,900 total
  • Conversion
    XENOPORT INC

    Series D Preferred Stock

    2005-06-07−102,527→ 0 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+73,751→ 855,371 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+217,120→ 781,620 total
  • Conversion
    ICAGEN INC

    Series G-1 Convertible Preferred Stock

    2005-02-08−73,751→ 0 total
  • Conversion
    ICAGEN INC

    Series D Convertible Preferred Stock

    2005-02-08−538,909→ 0 total
  • Conversion
    ICAGEN INC

    Series H Convertible Preferred Stock

    2005-02-08−110,625→ 0 total
  • Conversion
    ICAGEN INC

    Series F Convertible Preferred Stock

    2005-02-08−217,120→ 0 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+110,625→ 965,996 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+538,909→ 564,500 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+73,751→ 855,371 total
  • Conversion
    ICAGEN INC

    Series F Convertible Preferred Stock

    2005-02-08−217,120→ 0 total
  • Conversion
    ICAGEN INC

    Series H Convertible Preferred Stock

    2005-02-08−110,625→ 0 total
  • Conversion
    ICAGEN INC

    Series G-1 Convertible Preferred Stock

    2005-02-08−73,751→ 0 total
  • Conversion
    ICAGEN INC

    Series D Convertible Preferred Stock

    2005-02-08−538,909→ 0 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+538,909→ 564,500 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+217,120→ 781,620 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+110,625→ 965,996 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Series D Convertible Preferred Stock

    2004-04-08−823,256→ 0 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2004-04-08+271,428→ 271,428 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2004-04-08+201,555→ 472,983 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2004-04-08+274,418→ 747,401 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Series C Convertible Preferred Stock

    2004-04-08−566,400→ 0 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Series D Convertible Preferred Stock

    2004-04-08−823,256→ 0 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Series C Convertible Preferred Stock

    2004-04-08−566,400→ 0 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2004-04-08+274,418→ 747,401 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2004-04-08+271,428→ 271,428 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2004-04-08+201,555→ 472,983 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Series B Convertible Preferred Stock

    2004-04-08−814,286→ 0 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Series B Convertible Preferred Stock

    2004-04-08−814,286→ 0 total

Companies

3

Recent Filings

3

Address

30 ROCKEFELLER PLAZA, ROOM 5508

NEW YORK, NY, 10112

View on SEC.gov